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Ataxia oculomotor apraxia 1 (AOA1) results from mutations in aprataxin, a component of DNA strand break
repair that removes AMP from 5 termini. Despite this, global rates of chromosomal strand break repair are
normal in a variety of AOA1 and other aprataxin-defective cells. Here we show that short-patch single-strand
break repair (SSBR) in AOA1 cell extracts bypasses the point of aprataxin action at oxidative breaks and stalls
at the final step of DNA ligation, resulting in the accumulation of adenylated DNA nicks. Strikingly, this defect
results from insufficient levels of nonadenylated DNA ligase, and short-patch SSBR can be restored in AOA1
extracts, independently of aprataxin, by the addition of recombinant DNA ligase. Since adenylated nicks are
substrates for long-patch SSBR, we reasoned that this pathway might in part explain the apparent absence of
a chromosomal SSBR defect in aprataxin-defective cells. Indeed, whereas chemical inhibition of long-patch
repair did not affect SSBR rates in wild-type mouse neural astrocytes, it uncovered a significant defect in
Aptx/ neural astrocytes. These data demonstrate that aprataxin participates in chromosomal SSBR in vivo
and suggest that short-patch SSBR arrests in AOA1 because of insufficient nonadenylated DNA ligase.
Oxidative stress is an etiological factor in many neurological
diseases, including Alzheimer’s disease, Parkinson’s disease,
and Huntington’s disease. One type of macromolecule dam-
aged by reactive oxygen species is DNA, and oxidative damage
to DNA has been suggested to be a significant factor in these
and other neurological conditions (2). In particular, a number
of rare hereditary neurodegenerative disorders have provided
direct support for the notion that unrepaired DNA damage
causes neural dysfunction. Not least of these are the recessive
spinocerebellar ataxias, a number of which are associated with
mutations in DNA damage response proteins (17). The arche-
typal DNA damage-associated spinocerebellar ataxia is ataxia-
telangiectasia (A-T), in which mutations in ATM protein result
in defects in the detection and signaling of DNA double-strand
breaks (DSBs) (3). A-T-like disorder is a related disease that
exhibits neurological features similar to those of A-T, resulting
from mutation of Mre11, a component of the MRN complex
that operates in conjunction with ATM during DSB detection
and signaling (28).
Two additional spinocerebellar ataxias are spinocerebellar
ataxia with axonal neuropathy 1 (SCAN1) and ataxia oculo-
motor apraxia 1 (AOA1), in which the TDP1 and aprataxin
proteins are mutated, respectively (9, 19, 27). Both TDP1 and
aprataxin are components of the DNA strand break repair
machinery (recently reviewed in references 6 and 24). Whereas
SCAN1 is currently limited to nine individuals from a single
family, AOA1 is one of the commonest recessive spinocere-
bellar ataxias. Aprataxin is a member of the histidine triad
superfamily of nucleotide hydrolases/transferases and has been
reported to remove phosphate and phosphoglycolate moieties
from the 3 termini of DNA strand breaks (26). Aprataxin can
also remove AMP from a variety of ligands in vitro, including
adenosine polyphosphates, AMP-lysine, AMP-NH2 (adenine
monophosphoramidate), and adenylated DNA in which AMP
is covalently attached to the 5 terminus of a DNA single-
strand break (SSB) or DSB (1, 16, 23, 25). To date, aprataxin
activity is greatest on AMP-DNA, suggesting that this may be
the physiological substrate of this enzyme.
In vitro, DNA strand breaks with 5-AMP termini can arise
from premature DNA ligase activity. DNA ligases adenylate 5
termini at DNA breaks to enable nucleophilic attack of the
resulting pyrophosphate bonds by 3-hydroxyl termini, thereby
resealing the breaks. However, DNA adenylation by DNA
ligases can occur prematurely, before a 3-hydroxyl terminus is
available. Aprataxin reverses these premature DNA adenyla-
tion events, in vitro at least, effectively “resetting” the DNA
ligation reaction to the beginning (1). Whether or not 5-AMP
arises in DNA in vivo or is a physiological substrate of
aprataxin, however, is unknown. Moreover, attempts to mea-
sure DNA strand break repair rates in vivo are conflicting and
have failed to identify a consistent defect in DNA SSB repair
(SSBR) or DSB repair (DSBR) in AOA1 cells (14, 15, 20). It
is thus not clear whether or not defects in DNA strand break
repair can account for this neurodegenerative disease.
Here we have resolved the discrepancy between the require-
ments for aprataxin in vitro and in vivo by identifying the stage
at which SSBR reactions fail in vitro and by carefully analyzing
chromosomal SSBR rates in vivo. We show that short-patch
SSBR reactions are defective in AOA1 cell extracts at the final
step of DNA ligation, resulting in the accumulation of adeny-
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lated DNA nicks, and that this defect can be rescued in AOA1
extracts independently of aprataxin by addition of recombinant
DNA ligase. We also find that treatment with aphidicolin, an
inhibitor of DNA polymerase  (Pol ) and Pol ε, unveils a
measurable defect in chromosomal SSBR in Aptx/ primary
neural astrocytes, suggesting that the adenylated nicks that
arise from the short-patch repair defect can be channeled into
long-patch repair in vivo. These data demonstrate that
aprataxin participates in chromosomal SSBR and suggest that
this process arrests in AOA1, at oxidative SSBs, due to insuf-
ficient levels of nonadenylated DNA ligase.
MATERIALS AND METHODS
Preparation of adenylated DNA substrates. Oligonucleotide duplexes contain-
ing an SSB with a 5-AMP terminus and either a 1-bp gap with a 3-phosphate
terminus or a nick with a 3-hydroxyl terminus were prepared as follows. A
25-mer (5-GACATACTAACTTGAGCGAAACGGT) was labeled by phosphor-
ylation with T4 PNK and [-32P]ATP and was annealed with a 43-mer (5-CCG
TTTCGCTCAAGTTAGTATGTCAAAGCAGGCTTCAACGGAT) and a 17-
mer with a 3-phosphate terminus (17-mer-P) (5-TCCGTTGAAGCCTGCT
T-P). The labeled 25-mer in this duplex was then either adenylated at the 5
terminus by incubation with 1 U T4 DNA ligase at 30°C for 1 h in ligation buffer
(50 mM Tris-HCl [pH 7.5], 10 mM MgCl2, 5 mM dithiothreitol [DTT], 25 g/l
bovine serum albumin, 1 mM ATP) or mock adenylated in the absence of T4
DNA ligase. The labeled adenylated 25-mer was then separated from the labeled
nonadenylated 25-mer (and from the 17-mer and 43-mer) on a 15% denaturing
polyacrylamide gel electrophoresis (PAGE) gel, excised, and eluted from the
crushed gel in elution buffer (0.5 M ammonium acetate, 10 mM magnesium
acetate, 1 mM EDTA [pH 8.0]) overnight at room temperature. The eluted DNA
was then ethanol precipitated. The labeled mock-adenylated 25-mer was purified
in parallel. The labeled adenylated 25-mer was then reannealed with the 43-mer
and either the 17-mer-P (containing a 3 phosphate) or an 18-mer (5-TCCGT
TGAAGCCTGCTTT) to produce oligonucleotide duplexes harboring an adeny-
lated SSB with either a 1-bp gap and a 3-phosphate terminus or a nick with a
3-hydroxyl terminus, respectively. To measure the repair of 3 termini by PNK
or gap filling by Pol , the 17-mer-P or a 17-mer oligonucleotide lacking a 3
phosphate, respectively, was labeled with T4 PNK (phosphatase dead) and
[-32P]ATP and was annealed to the 25-mer and 43-mer. The substrate was
either mock adenylated or adenylated as described above and was purified on a
15% native PAGE gel. The final substrate contained a 1-bp gap with a 5 AMP
and either a 3 P or a 3 OH.
Purification of recombinant human SSBR proteins. Pol  was expressed in
Escherichia coli and purified by anion and cation exchange as previously de-
scribed (29), using a 1.6-ml Poros column on a Biocad Sprint chromatography
system (Applied Biosystems, United Kingdom). His-tagged PNK and His-tagged
DNA ligase III (Lig3) were expressed in the E. coli strain BL21(DE3) for 90
min at 20°C following addition of 1 mM isopropyl--D-thiogalactopyranoside
(IPTG). PNK was purified by cation-exchange chromatography followed by im-
mobilized metal chelate affinity chromatography (IMAC) as previously described
(30). Lig3 was purified by IMAC as described previously (7), followed by cation
exchange as described previously for PNK. His-tagged aprataxin was expressed
from pB352 (8) in BL21(DE3) by addition of 1 mM IPTG and incubation at 30°C
for 3 h. Aprataxin was purified by IMAC followed by cation exchange as de-
scribed above for PNK and Lig3.
Preparation of human lymphoblastoid cell extracts. Total-cell extracts were
prepared from 5 	 106 ConR2 (wild type [WT]) or Ap5 (AOA1) lymphoblastoid
cells or from Aptx/ and Aptx/ primary quiescent mouse astrocytes by lysis in
0.2 ml 20 mM Tris-HCl (pH 7.5), 10 mM EDTA, 1 mM EGTA, 100 mM NaCl,
1% Triton X-100, and 1/100 dilution of protease inhibitor cocktail (Sigma). The
extracts were clarified by centrifugation, quantified with a Bio-Rad DC protein
assay kit using bovine serum albumin as a standard, and then aliquoted and
snap-frozen.
In vitro repair of adenylated SSB substrates by recombinant proteins. For
reactions employing recombinant human proteins, a 25 nM concentration of the
indicated 32P-labeled substrate was incubated with the indicated concentrations
of recombinant protein for 1 h at 30°C in 25 mM HEPES (pH. 8.0), 130 mM KCl,
1 mM DTT, 10 mM MgCl2, 100 M deoxynucleoside triphosphates (dNTPs),
and 1 mM ATP unless otherwise indicated. Reactions were stopped by addition
of 1/3 volume of formamide gel loading buffer, and reaction products were
fractionated on 15% denaturing PAGE gels and analyzed by a phosphorimager.
For reactions employing cell extracts, 5 g of extract from WT lymphoblastoid
cells (ConR2) or AOA1 lymphoblastoid cells (Ap5) or from Aptx/ and Aptx/
primary quiescent mouse astrocytes was incubated with a 100 nM concentration
of the indicated 32P-labeled substrate for 1 h at 30°C in 25 mM HEPES (pH 8.0),
130 mM KCl, 1 mM DTT, and, unless otherwise indicated, 10 mM MgCl2, 100
M dNTPs, and 1 mM ATP. A 1,000-fold excess of a competitor oligonucleotide
with an unrelated sequence and a 5 phosphate (5-P-TCTGCTAGCATCGAT
CCATG-3) was added to reduce degradation of the labeled substrate by non-
specific nucleases. Reactions were stopped and products analyzed as described
above.
Cell culture. (i) Human cells. 1BR3 cells are primary human fibroblasts, and
ConR and ConR2 cells are lymphoblastoid cells, all from unrelated normal
individuals. fAp1 and fAp4 cells are AOA1 primary fibroblasts, and Ap3 and Ap5
cells are AOA1 lymphoblasts. ConR, Con R2, fAp1, fAp4, Ap3, and Ap5 cells
were kindly provided by Malcolm Taylor and, except for Ap5 and ConR2, have
been described previously (8). Ap1, Ap3, and Ap4 cells harbor the homozygous
APTX mutation W279X, which results in little or no aprataxin protein or activity
(1, 8), and Ap5 cells harbor a genomic deletion of APTX (M. Taylor, unpublished
data). Cells were cultured as described previously (8).
(ii) Primary mouse astrocytes. Aptx/ mice have been described previously
(1). The generation and characterization of nestin-Cre conditional Xrcc1/
mice will be described elsewhere. All animals were housed in individually ven-
tilated cabinets and were maintained in accordance with the guidelines of the
institutional animal care and ethical committee at the University of Sussex.
Mouse astrocytes were prepared from postnatal day 3 (P3) to P4 brains. Cortices
were dissociated by passage through a 5-ml pipette, and cells were resuspended
in Dulbecco’s modified Eagle’s medium and Ham’s F-12 nutrient mixture (1:1;
Gibco-BRL) supplemented with 10% fetal bovine serum, 1	 Glutamax, 100
U/ml penicillin, 100 g/ml streptomycin, and 20 ng/ml epidermal growth factor
(Sigma). Primary astrocytes were established in Primeria T-25 tissue culture
flasks (Falcon) at 37°C in a humidified oxygen-regulated (9%) incubator. The
culture medium was changed after 3 days, and astrocyte monolayers reached
confluence 3 days later. The purity of the astrocyte cultures was confirmed by
immunofluorescence using an anti-GFAP antibody (Sigma).
Alkaline comet assays. Cells (
3 	 105/sample) were incubated with 75 M
(mouse astrocytes), 50 M (human lymphoblastoid cells), or 75 M (primary
human fibroblasts) H2O2 for 10 min on ice or with the indicated doses of methyl
methanesulfonate (MMS) for 10 min at 37°C. Where indicated, cells were then
incubated in complete medium for the indicated repair periods at 37°C. To
inhibit long-patch DNA polymerases, cells were incubated with 50 M aphidi-
colin (Sigma) in complete medium for 30 min at 37°C. Cells were then either
mock treated or treated with H2O2 or MMS as described above in the continued
presence or absence of aphidicolin, as appropriate. Chromosomal DNA strand
breaks were then measured using alkaline comet assays as previously described
(5). Statistical analyses were performed using SPSS software.
RESULTS
Aprataxin interacts with the SSBR scaffold protein XRCC1,
raising the possibility that a defect in chromosomal SSBR
underlies the neuropathology of this disease. However, evi-
dence for a defect in SSBR in aprataxin-defective AOA1 cells
is conflicting (14, 15, 20). To resolve this issue, we employed
alkaline comet assays to compare chromosomal SSBR rates in
a variety of different aprataxin-defective cell types. It should be
noted that while alkaline comet assays measure both SSBs and
DSBs, these assays primarily measure SSBs following short
periods of treatment with H2O2 or MMS, because these agents
induce several orders of magnitude more SSBs than DSBs (4,
18). In contrast to the findings of a previous report (15), we
failed to observe a significant difference in chromosomal SSBR
rates between either lymphoblastoid cells (Fig. 1A) or primary
fibroblasts (Fig. 1B) from AOA1 patients and those from nor-
mal individuals following H2O2-induced oxidative stress. Be-
cause individual genetic variability might mask differences in
SSBR rates, we also compared chromosomal SSBR in qui-
escent primary astrocytes from Aptx/ mice and isogenic
Aptx/ littermate controls. Astrocytes were chosen because
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they are neural in origin and thus better reflect the type of cells
affected in AOA1. However, SSBR rates were similar in
Aptx/ and Aptx/ astrocytes following treatment with H2O2
(Fig. 1C). Aptx/ and Aptx/ astrocytes also accumulated
SSBs at similar rates during incubation with the alkyating agent
MMS, suggesting that the rate of SSB rejoining during DNA
base excision repair is also normal in Aptx/ cells (Fig. 1D). In
contrast, astrocytes lacking the core SSBR factor Xrcc1 exhib-
ited greatly reduced SSBR rates following treatment with ei-
ther H2O2 or MMS (Fig. 1C and D). It should be noted that we
also observed normal SSBR kinetics in Aptx/ postmitotic
cerebellar granule neurons (data not shown). We conclude
from these experiments that AOA1 and other aprataxin-defec-
tive cells lack a measurable defect in the global rate of chro-
mosomal SSBR.
In contrast to the findings of cellular SSBR assays, protein
extracts from Aptx/ astrocytes and Aptx chicken DT40 cells
are unable to support short-patch repair of adenylated oxida-
tive SSBs in vitro (1). To resolve this discrepancy, we examined
whether this was also true in AOA1 lymphoblastoid cell ex-
tracts. To measure short-patch SSBR, we employed an oligo-
nucleotide duplex harboring a 1-bp gap with 3-phosphate ter-
mini, a substrate that mimics one of the commonest types of
oxidative SSB arising in cells (Fig. 2A, top). The SSB also
possesses a 5 AMP and is therefore a substrate for aprataxin.
In agreement with previous experiments with neural extracts
(1), WT extracts efficiently removed AMP from 5 termini and
repaired the SSBs, as indicated by the respective appearance of
the 32P-labeled 25-mer and the 32P-labeled 43-mer (Fig. 2A,
lanes 6 to 8). In contrast, AOA1 extracts did not (Fig. 2A, lanes
3 to 5). Importantly, SSBR was proficient in AOA1 extracts if
the initial SSB lacked 5 AMP (Fig. 2B). A number of trun-
FIG. 1. Normal rates of chromosomal SSBR in cells lacking aprataxin. (A) AOA1 lymphoblastoid cells were incubated in the absence () or
presence () of 50 M H2O2 (15 min on ice), followed by incubation in a drug-free medium for the indicated repair period at 37°C. Chromosomal
DNA strand breaks were then measured by alkaline comet assays. (B) AOA1 primary fibroblasts were treated in the absence () or presence ()
of 75 M H2O2 (15 min on ice) and processed as described for panel A. Insets in panels A and B contain the same data as in the main panels but
plotted as percent damage remaining. (C) WT, Aptx/, and Xrcc1/ primary quiescent astrocytes were incubated in the absence () or presence
() of 75 M H2O2 (10 min on ice), followed by incubation in a drug-free medium for the indicated repair period at 37°C. Chromosomal DNA
strand breaks were then measured by alkaline comet assays. (D) WT, Aptx/, and Xrcc1/ primary quiescent astrocytes were incubated in the
absence () or presence of the indicated concentration of MMS (10 min at 37°C). Chromosomal DNA strand breaks were then measured by
alkaline comet assays.
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cated oligonucleotide fragments were generated by nonspecific
nucleolytic activity in these experiments, which represented
degradation of the 3 terminus of the 32P-labeled 25-mer. How-
ever, this activity did not account for the short-patch repair
defect in AOA1 cell extracts, which was fully complemented by
the addition of recombinant aprataxin (Fig. 2A, lanes 9 to 11).
The appearance of ligated product in these experiments was
dependent on the presence of dNTPs, confirming that these
experiments measured gap repair rather than ligation across
the 1-bp gap (data not shown).
The predicted pathway for short-patch repair of SSBs har-
boring 5 AMP in WT cells is depicted in Fig. 3A. It was
considered likely that this pathway arrests in AOA1 extracts at
the very beginning, prior to 3-DNA end processing by PNK
and/or DNA gap filling by Pol , because the presence of AMP
at the 5 terminus might occlude access to the 3 terminus.
Surprisingly, however, the 3-phosphatase activity of PNK was
similar irrespective of whether the SSB possessed 5 AMP or
not, under conditions in which PNK was limiting (Fig. 3B).
Similar results were observed for DNA gap filling by Pol ,
with similar amounts of the 32P-labeled 17-mer converted into
a 32P-labeled 18-mer irrespective of the presence or absence of
5 AMP (Fig. 3C). These experiments suggested that neither
PNK nor Pol  activity is affected by the presence of 5 AMP
at these time points, and thus short-patch SSBR might fail in
AOA1 extracts at the final step of DNA ligation, resulting in
the accumulation of adenylated DNA nicks (Fig. 3D).
To confirm this hypothesis, we compared WT and AOA1
extracts for their abilities to ligate adenylated nicks. Indeed,
whereas adenylated nicks were efficiently ligated by extracts
from WT cells, they remained largely unligated in reaction
mixtures containing AOA1 cell extracts (Fig. 4A). The finding
that short-patch repair in AOA1 arrests during DNA ligation is
surprising, because adenylated nicks are normal intermediates
of DNA ligation and are normally rapidly resealed by nonade-
nylated DNA ligase (11). Normally, the nonadenylated DNA
ligase required for this purpose is created during, and tightly
coupled with, adenylation of the 5 terminus of the break by an
adenylated DNA ligase (Fig. 4B). However, in the absence of
aprataxin, DNA nicks may accumulate in a preadenylated state
and therefore require preexisting pools of nonadenylated
DNA ligase. While both nonadenylated and adenylated DNA
ligases exist in cells, the former may be very limited because
the readenylation of DNA ligases by cellular ATP is very rapid.
Consequently, we reasoned that the DNA ligation defect in
AOA1 may reflect insufficient cellular levels of nonadenylated
DNA ligase. To test this hypothesis, we examined the impact of
supplementing short-patch SSBR reaction mixtures in AOA1
cell extracts and Aptx/ mouse neural astrocyte extracts with
recombinant DNA ligase. Strikingly, addition of T4 ligase re-
stored short-patch SSBR efficiency in both AOA1 cell extracts
and Aptx/ neural cell extracts to a level similar to that ob-
served in WT extracts (Fig. 4C and D, compare lanes 6 and 10).
Importantly, complementation was more efficient in the ab-
sence of ATP than in its presence, supporting the notion that
it was the nonadenylated subfraction of T4 ligase that was
responsible for complementation (Fig. 4C and D, compare
lanes 8 and 10). Similar results were observed for AOA1 cell
extracts if T4 ligase was replaced with human DNA ligase 3,
albeit to a lesser extent (Fig. 5A).
The data described above suggest that short-patch repair of
some adenylated SSBs can occur independently of aprataxin if
sufficient nonadenylated DNA ligase is available. To confirm
this idea, we attempted to reconstitute this aprataxin-indepen-
dent SSBR pathway using recombinant proteins. As expected,
the repair of adenylated gaps by PNK, Pol , and Lig3 was
FIG. 2. Aprataxin-dependent short-patch SSBR of 5-AMP SSBs in AOA1 lymphoblastoid extracts. (A) Defective short-patch SSBR in AOA1
extracts and its complementation by recombinant aprataxin. (Top) Cartoon of the oligonucleotide duplex employed for these experiments,
containing a 1-bp gap, a 3-phosphate terminus, and a 5-AMP terminus. The 5 phosphate to which AMP is covalently linked is labeled with 32P.
The position of this label restricts the assay to measurements of short-patch repair events only. Nucleotide lengths are shown. (Bottom) Portions
(0.1 g, 1.0 g, or 5.0 g) of either WT (ConR2) or AOA1 (Ap5) cell extracts were incubated for 60 min at 30°C with a 32P-labeled 5-AMP SSB
substrate (25 nM) in the absence (left) or presence (right) of recombinant human aprataxin (APTX) (100 nM). Reaction products were
fractionated and detected as described in Materials and Methods. The 32P-labeled 25-mer containing (AMP-32P-25) or lacking (32P-25) 5 AMP
was fractionated in parallel for size markers (Mks). The position of the repaired 32P-labeled 43-mer is also indicated. Asterisks indicate nonspecific
nucleolytic products. (B) Normal short-patch repair of SSBs lacking 5 AMP in AOA1 cell extracts. (Top) Cartoon of the oligonucleotide duplex
employed for these experiments, containing a 1-bp gap, a 3-phosphate terminus, and a normal 32P-labeled 5-phosphate terminus. WT (ConR2)
or AOA1 (Ap5) cell extracts (5 g) were incubated for 60 min at 30°C with a 32P-labeled SSB substrate lacking 5 AMP (100 nM). Reaction
products were fractionated and detected as described in Materials and Methods.
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dependent on aprataxin in the presence of ATP, conditions
under which Lig3 is largely adenylated (Fig. 5B). However, in
the absence of ATP, short-patch repair of 5-AMP SSBs oc-
curred independently of aprataxin. Taken together, these ex-
periments indicate that short-patch repair arrests in AOA1 cell
extracts at the final step of DNA ligation, due to insufficient
levels of nonadenylated DNA ligase.
Importantly, the finding that short-patch repair failed during
DNA ligation provides a possible explanation for the absence
of a measurable defect in chromosomal SSBR in AOA1, fol-
lowing oxidative stress. This is because adenylated DNA nicks
might be channeled into long-patch SSBR reactions, during
which the adenylated 5 terminus is displaced by extended
DNA gap filling and then clipped off nucleolytically, avoiding
the requirement for either aprataxin or preexisting pools of
nonadenylated DNA ligase. While our in vitro assay was not
capable of measuring long-patch repair reactions, this process
might operate efficiently at adenylated nicks within a chromo-
somal context. To examine this possibility, we compared chro-
mosomal SSBR rates in WT and Aptx/ quiescent mouse
neural astrocytes in the presence and absence of aphidicolin,
an inhibitor of the DNA polymerases Pol  and Pol ε, which
are implicated in long-patch repair reactions (10, 13, 22). Strik-
ingly, whereas aphidicolin did not measurably reduce SSBR
rates in WT astrocytes following H2O2 treatment, it signifi-
cantly slowed SSBR in Aptx/ astrocytes (Fig. 6A). Aphidi-
colin also selectively slowed short-patch base excision repair in
AOA1 cells, as indicated by the accumulation of higher steady-
state levels of chromosomal DNA strand breaks in Aptx/
astrocytes than in WT astrocytes during short incubations with
the DNA-alkylating agent MMS (Fig. 6B). The fact that SSBR
in Aptx/ cells was slowed rather than prevented by aphidi-
colin most likely reflects the fact that only a subset of H2O2-
and MMS-induced SSBs possess adenylated 5 termini. Nev-
ertheless, the presence of a measurable defect in chromosomal
SSBR in Aptx/ cells indicates that a significant fraction of
endogenous SSBs arising from oxidative stress and DNA base
damage are substrates for aprataxin.
In summary, we demonstrate here that aprataxin is required
for SSBR in vivo and suggest that short-patch SSBR is defec-
tive in AOA1 cells, at oxidative SSBs, due to insufficient levels
of nonadenylated DNA ligase.
DISCUSSION
AOA1 is one of the commonest recessive hereditary spino-
cerebellar ataxias identified to date. This disease results from
mutations in aprataxin, a component of the DNA strand break
FIG. 3. Removal of 5 AMP by aprataxin is not required for end processing by PNK or gap filling by Pol . (A) Cartoon of aprataxin-dependent
short-patch repair of adenylated SSBs in WT cells. (B) 5 AMP does not affect processing of 3-phosphate termini by PNK. An SSB substrate (25
nM) lacking or containing 5 AMP as indicated (top) was incubated either with 25 nM, 50 nM, 125 nM, or 250 nM recombinant human PNK or
without PNK () for 1 h at 30°C. Reaction products were fractionated by denaturing PAGE and detected by phosphorimaging. Note that the 5
terminus of the 17-mer is labeled with 32P in these experiments to allow detection of 3 end processing. The position of the 17-mer harboring 3
phosphate (17-P) or 3 hydroxyl (3-OH) is indicated. (C) 5 AMP does not affect gap filling by Pol . An SSB substrate (25 nM) lacking or
containing 5 AMP as indicated (top) was incubated either with 5 nM, 15 nM, 30 nM, or 100 nM purified recombinant human Pol  or without
Pol  () for 1 h at 30°C. Reaction products were fractionated by denaturing PAGE and detected by phosphorimaging. The positions of the 17-mer
and 18-mer are indicated as markers. (D) Cartoon depicting APTX-independent repair of adenylated SSBs in AOA1. Note the hypothetical
blockage of this process at the final step of DNA ligation.
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repair machinery that removes AMP from 5 termini during
short-patch SSBR reactions in vitro (1, 9, 19). However,
whether or not aprataxin is required for chromosomal DNA
strand break repair in vivo is unclear. This is because the
occurrence of DNA strand breaks with 5 AMP has not yet
been demonstrated. Moreover, attempts to detect a chromo-
somal DNA repair defect in AOA1 cells have proved conflict-
ing and unclear (14, 15, 20). To resolve the latter issue, we
carefully measured chromosomal SSBR rates in a variety of
aprataxin-defective cell lines, including genetically matched
FIG. 4. Short-patch SSBR fails in AOA1 due to insufficient levels of nonadenylated DNA ligase. (A) AOA1 cell extracts cannot efficiently ligate
adenylated DNA nicks. Total WT (ConR2) or AOA1 (Ap5) lymphoblastoid cell extracts (6.25 g) were incubated with a 32P-labeled adenylated
nicked substrate (25 nM) (top) for the indicated times at 30°C. Reaction products were fractionated by denaturing PAGE and detected by
phosphorimaging. A 32P-labeled 25-mer containing 5 AMP (AMP-25) and one lacking 5 AMP were fractionated for size markers (Mks). The
position of the 43-mer ligated product is indicated. (B) Cartoon depicting ligation of a nonadenylated DNA nick by DNA ligase. (i) An adenylated
DNA ligase molecule transfers AMP to the 5-phosphate terminus of a DNA nick, resulting in an adenylated nick and a nonadenylated ligase
molecule. (ii) The nonadenylated DNA ligase molecule rapidly catalyzes a nucleophilic attack of the pyrophosphate bond linking AMP to DNA,
resulting in nick ligation and the release of AMP. The nonadenylated DNA ligase molecule is readenylated (dashed arrow) in readiness for the
next ligation event. (C) Complementation of the SSBR defect in AOA1 lymphoblastoid extracts by recombinant T4 DNA ligase. Total WT
(ConR2) or AOA1 (Ap5) lymphoblastoid cell extracts (5 g) were incubated with a 32P-labeled 5-AMP SSB substrate (25 nM) for 1 h at 30°C
in the presence or absence of 1 mM ATP and/or 2 U of T4 DNA ligase, as indicated. Reaction products were fractionated by denaturing PAGE
and detected by phosphorimaging. The positions of the 32P-labeled 43-mer reaction product and the 32P-labeled 25-mer containing or lacking 5
AMP are indicated. M’rkers, markers. (D) Complementation of the SSBR defect in Aptx/ primary astrocyte extracts by recombinant T4 DNA
ligase. Aptx/ (/) or Aptx/ (/) mouse astrocyte extracts (5 g) were incubated with a 32P-labeled 5-AMP SSB substrate (25 nM) for 1 h
at 30°C in the presence or absence of 1 mM ATP and/or 2 U of T4 DNA ligase, as indicated. Reaction products were fractionated by denaturing
PAGE and detected by phosphorimaging. The positions of the 32P-labeled 43-mer reaction product and the 32P-labeled 25-mer containing or
lacking 5 AMP are indicated.
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WT and Aptx/ quiescent neural cells. These experiments
revealed that the overall rate of SSBR is normal in aprataxin-
defective cells. Notably, we also failed to detect reduced rates
of DSBR in AOA1 (unpublished observations).
To resolve the discrepancy between the requirement for
aprataxin for SSBR in vitro versus that in vivo, we identified
the stage at which short-patch SSBR fails in AOA1 in vitro.
Notably, 3-DNA end processing and DNA gap filling occurred
normally during SSBR in the absence of aprataxin, despite the
persistence of AMP on the 5 terminus. However, SSBR reac-
tions subsequently stalled at the final step of DNA ligation,
resulting in the accumulation of adenylated DNA nicks. This
was surprising, because adenylated DNA nicks are normal,
indeed prerequisite, intermediates of DNA ligation reactions,
requiring only nonadenylated DNA ligase to reseal the breaks.
We therefore reasoned that DNA ligation might fail in AOA1
cell extracts because of insufficient levels of nonadenylated
DNA ligase. This would be consistent with the notion that
while DNA ligases exist in both adenylated and nonadenylated
states, the former predominates in cells because of the cellular
ATP concentration. This would not pose a problem in WT
cells, in which aprataxin activity ensures that DNA nicks aris-
ing during SSBR are not preadenylated and thus are substrates
for adenylated DNA ligase. However, in AOA1 cells, DNA
nicks can arise in a preadenylated state during SSBR which
thus require nonadenylated DNA ligase. In short, we propose
that while all cells possess low levels of nonadenylated ligase,
due to the rapid adenylation of free ligase molecules by cellular
ATP, only in aprataxin-defective cells do preadenylated nicks
arise at a level that exceeds the availability of nonadenylated
ligase.
Confirmation that short-patch SSBR fails in AOA1 due to
insufficient levels of nonadenylated DNA ligase emerged from
our finding that addition of recombinant T4 DNA ligase or
human Lig3 restored short-patch SSBR in AOA1 extracts
and Aptx/ quiescent astrocyte extracts in the absence of
aprataxin. Importantly, complementation was more efficient if
ATP was omitted from the reaction mixtures, supporting the
notion that the complementing factor was nonadenylated
DNA ligase. This may also explain the apparent difference
between the abilities of T4 DNA ligase and Lig3 to comple-
ment the defect (compare Fig. 4C and 5A), since it is likely that
the relative amounts of nonadenylated ligase present in the
two DNA ligase preparations were different.
The finding that adenylated nicks accumulate during short-
patch SSBR in AOA1 provides a possible explanation for the
normal rate of chromosomal SSBR observed in this disease.
This is because adenylated nicks can be channeled into long-
FIG. 5. Complementation of the SSBR defect in AOA1 lymphoblastoid cell extracts by recombinant human Lig3 and reconstitution of
aprataxin-independent SSBR with recombinant human proteins. (A) Complementation of the SSBR defect in AOA1 lymphoblastoid cell extracts
by recombinant DNA ligase III (Lig3). Total WT or AOA1 lymphoblastoid cell extracts (5 g) were incubated with a 32P-labeled 5-AMP SSB
(100 nM) substrate for 1 h at 30°C in the presence or absence of 1 mM ATP and/or 8 nM, 24 nM, or 72 nM Lig3, as indicated. (B) Reconstitution
of aprataxin-independent SSBR with recombinant human proteins. A 5-AMP SSB substrate (60 nM) was incubated with 250 nM recombinant
PNK, 100 nM Pol , and 80 nM Lig3 in the presence or absence of 100 nM aprataxin (APTX) and 1 mM ATP, as indicated, for 1 h at 30°C.
Reaction products were fractionated by denaturing PAGE and detected by phosphorimager.
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patch SSBR. In this pathway, damaged 5 termini are displaced
as a single-stranded flap during gap filling from the 3 terminus
and cleaved off by Flap endonuclease 1 (FEN1) (reviewed in
reference 12). This process would not be detected by the short-
patch repair assays employed in the current work, because
oligonucleotide duplexes of the type employed here are not
good substrates for long-patch repair reactions and because
cleavage of the single-strand flap would remove the 32P label in
our substrates. However, to determine whether long-patch re-
pair might compensate for the loss of short-patch repair in
aprataxin-defective cells, we exploited the observation that
long-patch SSBR employs the aphidicolin-sensitive DNA poly-
merases Pol  and/or Pol ε (10, 13, 22). Because inhibition of
Pol  and/or Pol ε also prevents DNA replication during S
phase and can thus impact DNA metabolism independently of
long-patch SSBR, we employed quiescent primary astrocytes
for these experiments. Strikingly, whereas preincubation with
aphidicolin did not affect SSBR rates in WT cells, it revealed a
significant chromosomal SSBR defect in Aptx/ primary qui-
escent astrocytes following treatment with either H2O2 or
MMS. SSBR was slowed rather than prevented by aphidicolin,
perhaps reflecting the fact that only a subset of DNA strand
breaks induced by these agents possess 5-AMP termini.
Alternatively, it is possible that Aptx/ quiescent astrocytes
possess additional, partially overlapping SSBR pathways.
Nevertheless, these data demonstrate, for the first time, the
involvement of aprataxin in chromosomal SSBR in vivo.
It remains to be determined whether long-patch repair can
also compensate for defective short-patch repair in AOA1
cells, as appears to be the case in Aptx/ mouse neural cells.
However, if this is the case, why do aprataxin mutations result
in disease? One possibility is that a subset of SSBs arise at
which long-patch repair cannot operate. For example, it is
possible that aprataxin is also required to repair specific types
of damaged 3 termini (26). Long-patch repair would be un-
able to operate at such breaks, because no 3-hydroxyl primer
terminus is available for DNA gap filling. Alternatively, since
aprataxin is associated with the DSBR machinery (8), it is
possible that unrepaired DSBs might account for AOA1. It
should be noted, however, that we have so far failed to detect
a DSBR defect in AOA1 or Aptx/ cells (unpublished obser-
vations). Finally, it is possible that long-patch repair is not
operative or is attenuated in the specific cell types that are
affected in AOA1. For example, a number of replication-asso-
ciated proteins, including several of those implicated in long-
patch repair, are downregulated in certain differentiated cell
types (21). Thus, it will now be of interest to expand the
experiments described in this study to other cell types, includ-
ing those neural cell types most likely affected in AOA1.
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